Clarity for Your Journey.

Non-Invasive Prenatal Testingl

Planning for a family comes with a million questions, but prenatal carrier screening can give you clear, actionable answers. This simple, non-invasive genetic test determines if you or your partner carry inherited gene changes that could be passed on to your future child, even if neither of you has any symptoms or family history of a condition. By screening for disorders like Cystic Fibrosis, Spinal Muscular Atrophy (SMA), and Sickle Cell Anemia, our comprehensive panels provide invaluable insights before or during pregnancy. Ultimately, it gives you the knowledge and peace of mind needed to make informed healthcare choices for your growing family.

Hereditary Breast
& Ovarian Cancer Panel

$4,325

Discover the Big Reveal, Safely and Early Skip the wait and find out if you’re having a boy or a girl as early as 9 weeks into your pregnancy. Using a simple, risk-free maternal blood sample, our highly accurate Prenatal Gender Testing analyzes fetal DNA to give you reliable results weeks ahead of a traditional ultrasound. It’s the perfect, safe way to start planning, decorating, and celebrating your growing family.

Prenatal Carrier Screening

$2,225.00

Proactive Genetic Insights for a Healthy Future Ensure your baby gets the healthiest start possible. Prenatal Carrier Screening looks beneath the surface to identify whether you or your partner carry inherited genetic variants for conditions like cystic fibrosis or spinal muscular atrophy. This gentle, non-invasive test gives you invaluable knowledge and peace of mind, empowering you to make informed healthcare choices for your family's future.

Certainty Before Arrival

Hereditary Breast Cancer

$4,325

Hereditary Endoctrine Cancer

$2,325

Safe & Accurate. Prenatal

This comprehensive genetic blood test analyzes 18 key genes linked to inherited cancer risks. It identifies gene mutations that significantly increase a person's lifetime probability of developing breast cancer as well as related cancers—such as ovarian, pancreatic, prostate, and colon cancers—enabling proactive screening, early detection, and personalized prevention strategies.

Hereditary Gastrointestinal & Colorectal Cancer Screen

$4,325

This comprehensive genetic test analyzes 20 key genes associated with inherited colorectal and digestive system cancers. It identifies genetic variants that significantly increase a person's lifetime risk for colon, rectal, stomach, and related cancers—enabling early colonoscopy screening, polyp prevention, and tailored risk management.

Expanded 7-Gene High-Risk Breast Cancer Screen

$4,325

This expanded genetic test analyzes seven high-risk genes (BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, and TP53) associated with inherited breast cancer. By evaluating additional susceptibility genes beyond traditional BRCA testing, it provides a higher diagnostic yield to guide early screening, clinical surveillance, and risk-reduction strategies for at-risk individuals and their families.

Female Inherited Cancer Gene
High-Risk Breast Cancer Screen

$685

This targeted genetic test evaluates key genes linked to inherited cancers of the female reproductive system. It identifies mutations that significantly increase lifetime risks for ovarian, fallopian tube, and uterine cancers, enabling personalized monitoring, early detection strategies, and proactive risk-reduction options.

Comprehensive Solid Tumor
Profiling Test

A-phlebotomist-drawing-blood-from-a-patient-in-a-comfortable-home-setting-with-natural-day

$7,235

Full-Spectrum Multi-Cancer Genetic Screen

$4,685

The Comprehensive Hereditary Cancer Panel includes 66 genes associated with a broad spectrum of hereditary cancers. This can include, but is not limited to, cancers of the breast, colon, endometrium, stomach, urinary tract, ovary, pancreas, prostate, rectum, neuroendocrine system, thyroid, adrenal glands, paraganglia, and other tissues.…

Hereditary Diffuse Gastric & Lobular Breast Cancer Screen

$685

This single-gene genetic test performs full sequencing and deletion/duplication analysis of the CDH1 (E-cadherin) gene. It identifies inherited mutations responsible for Hereditary Diffuse Gastric Cancer (HDGC) and invasive lobular breast cancer, empowering high-risk individuals and families to pursue early endoscopic surveillance, proactive screening, and preventative options.

Hereditary Ovarian & Uterine Cancer Risk Screen

$1,225

This diagnostic tissue test analyzes an invasive breast cancer biopsy to evaluate HER2/neu gene amplification using fluorescence in situ hybridization (FISH), with automatic follow-up immunohistochemistry (IHC) if results are borderline. Determining HER2 status is essential for guiding cancer staging and selecting targeted anti-HER2 therapies.

Comprehensive Tumor
Profiling Panel

$8,335

Solid TumorSEQ™ is an advanced diagnostic tissue test that sequences 523 key genes within a solid tumor biopsy. By analyzing the unique genetic mutations and biomarkers driving a patient's cancer, it provides oncologists with a comprehensive genomic map to select personalized targeted therapies, immunotherapies, and matching clinical trials.

Rapid Prenatal Amnio
Chromosome Imaging

Family-gathering-scene-shows-multi-generational-group-smiling-and-embracing-in-warm-home-s

LiquidSEQ™ with Reflex to Solid TumorSEQ™ is an advanced two-in-one cancer test that first analyzes circulating tumor DNA in a patient's blood (liquid biopsy) across 523 genes. If the blood sample yields insufficient data, the lab automatically reflexes to analyzing physical tumor tissue—ensuring fast, non-invasive biomarker profiling to guide targeted cancer therapies.

Cancer Antigen
Monitoring Panel

This rapid diagnostic prenatal test uses fluorescence molecular tagging on amniotic fluid cells to directly count chromosomes 13, 18, 21, X, and Y. By providing definitive diagnostic results within 2 to 3 days, it offers fast confirmation for Down syndrome, Trisomy 18, Trisomy 13, and sex chromosome variations following an abnormal blood screen or ultrasound finding.

LiquidSEQ™ with Reflex to Solid TumorSEQ™ is an advanced two-in-one cancer test that The Cancer Antigen (CA) 15-3 test is a blood test that measures levels of the CA 15-3 protein in the bloodstream. Primarily used in patients with advanced or previously treated breast cancer, this tumor marker helps oncologists monitor treatment effectiveness, track disease progression, and check for cancer recurrence.analyzes circulating tumor DNA in a patient's blood (liquid biopsy) across 523 genes. If the blood sample yields insufficient data, the lab automatically reflexes to analyzing physical tumor tissue—ensuring fast, non-invasive biomarker profiling to guide targeted cancer therapies.